Foley & Lardner LLP
ToolbarSearchPrintEmail this PageSaveHelp


Life Sciences


Ever more, U.S. patent reform, regulatory enforcement, pending health care reform, and technology convergence are issues driving the life sciences industry. The aging world population and pressures on global natural resources have presented the industry with vast opportunities as well as great challenges.

As the discovery and development of new blockbuster inventions becomes increasingly more elusive, life sciences companies are seeking to expand their product portfolios to meet the demands of the global market by balancing integration of scientific discovery and calculated business planning.

For more than 25 years, Foley's Life Sciences Industry Team has provided comprehensive legal services for life sciences enterprises. The cornerstone of our success has been our unique ability to blend technical and legal insights with an understanding of our clients' real-world business needs.

Technical Acumen in Applicable Scientific Sectors
Foley attorneys and professionals are uniquely capable of understanding our clients' technologies. Members of our Life Sciences Industry Team have research or commercial experience in related areas, including:


  • Agricultural biotechnology
  • Biochemistry
  • Biologics
  • Bio-pharmacology
  • Biophysics
  • Biotechnology
  • Cellular biology
  • Diagnostics
  • Endocrinology
  • Genetics
  • Materials sciences and engineering
  • Mechanical engineering
  • Medical devices
  • Molecular biology
  • Nanotechnology
  • Neurosciences
  • Nutraceuticals
  • Nutritional biochemistry
  • Organic chemistry
  • Pharmacology
  • Protein chemistry
  • Public health
  • Stem cells and regenerative medicine
  • Vaccines

Additionally, more than 45 attorneys and paraprofessionals hold Ph.D.s, and more than 40 hold Master's degrees in a relevant science.

Cross-Disciplinary Services for the Life Sciences Industry

Melding crucial legal disciplines in the areas of businessintellectual property (IP), health care, and U.S. Food and Drug Administration (FDA) regulatory law, Foley meets the diverse needs of today's life science enterprises.

Assisting Clients in the Global Market
Foley is ingrained in the thriving life sciences communities we represent. We know the life sciences industry and we understand the myriad factors that shape our clients' businesses; therefore, we are able to evolve to meet their evolving needs.



Contacts
Gabor Garai
Chair


Stephen B. Maebius
Chair


David L. Rosen
Chair


Judith A. Waltz
Chair


Related Professionals

News
Judy Waltz Quoted in Medicare Compliance Alert on Physician and Vendor Relationships

Judith Waltz Quoted in Report on Medicare Compliance on OIG Enforcement

Courtenay Brinckerhoff and George Best Quoted in BNA’s Life Sciences Law & Industry Report on Tafas v. Doll

More

Publications
Newsletter for Leaders in the Medical Device Industry – June 2009

Medical Device Company Indicted for Off-Label Marketing and Statements Made to FDA During Regulatory Inquiry

What You Should Know About Patent Reform

More
Newsletter Sign Up

Multimedia
IP Outlook in the Reform Era (58:29)

Significant Developments Trademark Counsel Need to be Aware of When Promoting and Protecting Brands Over the Internet (02:45)

Priority Issues For the New USPTO Leadership in 2009 and Beyond (01:51)

More



BriefcaseClient LoginContact UsSite Map



About Us Our Services Our People News & Events Publications Careers Multimedia Community Service Diversity Technology Management Offices View All Practices Search View All Press Room In the Headlines Events Articles Newsletters Law Students Laterals Professional Staff Search View All